Dr. Rodrigo Sánchez Bayona awarded by Instituto de Salud Carlos III to combine his work as a oncologist at the Breast Cancer Unit in Hosptial 12 de Octubre with clinic research at Cell Division and Cancer group.

Improving CDK4/6-targeted therapies in advanced breast cancer

Dr. Ruiz research will be focused in the design of new strategies to improve the current treatments in advance breast cancer. He will identify and characterize new therapeutic targets that will be combined with the current standard-of-care in metastatic breast cancer.

Centrosomes are key organelles for Neural Progenitor homeostasis during development. Disruption of centrosome dynamics alters neurodevelopment in an array of genetically-engineered mice as seen in microcephaly patients    Abstract Congenital microcephaly (MCPH)...

CDK4/6 inhibitors are effective in certain types of cancer because they stop the multiplication of tumour cells, but they cannot be used together with chemotherapy since chemotherapy only acts against cancer cells that are actively multiplying We changed this approach...

International Day of Women and Girl in Science, 2020. This year, CaixaForum Madrid organised an event for the International Day of Women and Girls in Science, and our lab mate Maria was invited, representing the Innovative program of La Caixa Foundation...

To celebrate this year’s Peer Review Week theme, ‘‘Quality in Peer Review,’’ the editors across Cell Press have nominated some of their best reviewers to give their philosophies on peer reviewing. Link: https://www.cell.com/cell/fulltext/S0092-8674(19)30963-8...